School personnel information

写真b

Organization 【 display / non-display

  • 1999.04.01 - 2006.03.31, Graduate School of Medicine, Research Assistant

  • 2006.04.01 - 2007.03.31, Osaka University Hospital, Associate Professor

  • 2007.04.01 - 2019.11.30, Osaka University Hospital, Associate Professor

  • 2019.12.01 - , Osaka University Hospital, Professor

  • 2013.04.01 - , Graduate School of Pharmaceutical Sciences

Education 【 display / non-display

Osaka University Faculty of Medicine  Graduated 1986.03
Osaka University Graduate School, Division of Medicine  Completed 1993.03

Research topics 【 display / non-display

  • translational research
    Pharmacology-related

  • Orthopedics-related, Biomedical engineering-related

  • Orthopedics-related

 

Academic Papers 【 display / non-display

  • Eribulin suppresses clear cell sarcoma growth by inhibiting cell proliferation and inducing melanocytic differentiation both directly and via vascular remodeling., Nakai S, Tamiya H, Imura Y, Nakai T, Yasuda N, Wakamatsu T, Tanaka T, Outani H, Takenaka S, Hamada K, Myoui A, Araki N, Ueda T, Yoshikawa H, Naka N, Molecular cancer therapeutics, 2019.12, Other

  • Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs., Nakai S, Tamiya H, Imura Y, Nakai T, Yasuda N, Wakamatsu T, Tanaka T, Outani H, Takenaka S, Hamada K, Myoui A, Araki N, Ueda T, Yoshikawa H, Naka N., Sci Rep. ,9(1):15812, 2019.11, Papers

  • Transplantation of autologous bone marrow-derived mesenchymal stem cells under arthroscopic surgery with microfracture versus microfracture alone for articular cartilage lesions in the knee: A multicenter prospective randomized control clinical trial. , Hashimoto Y, Nishida Y, Takahashi S, Nakamura H, Mera H, Kashiwa K, Yoshiya S, Inagaki Y, Uematsu K, Tanaka Y, Asada S, Akagi M, Fukuda K, Hosokawa Y, Myoui A, Kamei N, Ishikawa M, Adachi N, Ochi M, Wakitani S. , Regen Ther.,11:106-113, 2019.06, Papers

  • Three-Dimensional Corrective Osteotomy for Malunited Fractures of the Upper Extremity Using Patient-Matched Instruments: A Prospective, Multicenter, Open-Label, Single-Arm Trial, Oka K, Tanaka H, Okada K, Sahara W, Myoui A, Yamada T, Yamamoto M, Kurimoto S, Hirata H, Murase T, The Journal of bone and joint surgery. American volume,101(8) 710-721, 2019.04, Papers

  • ONO-1301 Enhances in vitro Osteoblast Differentiation and in vivo Bone Formation Induced by Bone Morphogenetic Protein, Kanayama S, Kaito T, Kitaguchi K, Ishiguro H, Hashimoto K, Chijimatsu R, Otsuru S, Takenaka S, Makino T, Sakai Y, Myoui A,, Spine, 2018.06, Papers

display all >>

Books 【 display / non-display

  • Special, Three-dimensionally engineered hydroxyapatite ceramics with interconnected pores as a bone substitute and tissue engineering scaffold., Myoui A, Tamai N, Nishikawa M, Yoshikawa H, Araki N, Nakase T, Akita S., Marcel Dekker, 2003.07

Patents / Utility models / Designs 【 display / non-display

  • Japan, Drug for prevention of cancer metastasis, Akira Myoui, Hideki Yoshikawa, Yuki Kishida, 3815736(Registration), 2003.07

  • United States, Ceramics for in vivo use, Akira Myoi, Koichi Imura, Tomoyuki Sugiyama, United States Patent 6821916B2(Registration), 2002.09, 2004.11

Awards 【 display / non-display

  • Excellent Paper Award, Akira Myoui, 13th Annual Meeting of the Japanese Association for Metastasis Research, 2004.08

  • Excellent Paper Award, Akira Myoui, 2nd Annual Meeting of the Japanese Society of Regenerative Medicine, 2003.03

  • Plenary Poster Award, Akira Myoui, 2nd Joint Meeting of the American Society for Bone and Mineral Research and the International Bone and Mineral Society., 1998.12